BlueNalu
ActiveOn the Alternative proteins Radar · not rankedAlternative proteins · United States
Develops cultivated bluefin tuna toro grown from fish cells for sushi restaurants, working with Asian food partners and awaiting US FDA review.
Why BlueNalu is not ranked yet
How the Radar works →The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. BlueNalu enters the ranking once its public data is sufficient for the AI to estimate it. Next Alternative proteins worldwide edition: 28 Feb 2027.
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| Jan 2026 | Convertible notes + preferred stock | USD 11M | Equity | Agronomics, Siddhi Capital, Lewis & Clark AgriFood, Griffith Foods, Pulmuone, Rich Products |
Mix of preferred shares and convertible notes; previous Series B of USD 33.5M (2023).
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Alternative proteins · worldwide | Radar | — | Edition 0 · Oct 2026 | 28 Feb 2027 |
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of BlueNalu as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in alternative proteins
Full alternative proteins ranking →Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.